Such a complex arrangement of individuals leads to considerable small-scale variation in tree stocking density; it was felt that problems encountered in selecting samples should become evident with such complexity.
The use of molecular markers for reliable identification of clinical samples should become an obligatory practice because it is necessary for a better understanding of the epidemiology of this zoonotic parasite.
Sampling of lineages should become more complete as one moves towards the root of the phylogeny, and therefore, the results of this truncation should test how robust our results are.
So, as sample sizes go up, the odds ratios should become more accurate, and the evidence that odds ratios differ from one (with an odds ratio of one implying no genetic effect) should become more statistically significant.
It should also be possible to state how much of a sample remains or what the activity or count should become after a given length of time.
Therefore, this approach should become of increasing interest when considering limited sample volumes, costs, high-throughput, and reproducibility.
As more viral genes of host origin are detected in environmental samples and cultured phage genomes, their evolutionary relationships with host genes should become clearer.
As the sample size of leaders, techniques, and reactions grows, this two-way communication channel should become as good as the very best consumer recommendation engine at offering content that is relevant to you.
As novel phages continue to be isolated from environmental samples using diverse bacterial hosts, the prevalence, distribution, and genetic basis of this phenotype should become more apparent.
Stereological and statistical calculations should become available to correct the number of partially sectioned cells in the LCM samples.
